{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:27Z","timestamp":1787800827201,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10620-026-09929-z","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:10:07Z","timestamp":1778127007000},"page":"4455-4461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Nutrition Landscape in Chronic Liver Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Bridgette B.","family":"McNally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"9929_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","volume":"74","author":"Jennifer C Lai","year":"2021","unstructured":"Lai Jennifer C, Tandon P, Bernal W et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the study of liver diseases. Hepatology 2021;74:1611\u20131644.","journal-title":"Hepatology"},{"key":"9929_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.14309\/ajg.0000000000003379","volume":"120","author":"Ashwani K Singal","year":"2025","unstructured":"Singal Ashwani K, Wong RJ, Dasarathy S et al. ACG clinical guideline: malnutrition and nutritional recommendations in liver disease. Off J Am Coll Gastroenterol ACG. 2025;120:950\u2013972.","journal-title":"Off J Am Coll Gastroenterol ACG."},{"key":"9929_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.7861\/clinmedicine.10-6-624","volume":"10","author":"J Saunders","year":"2010","unstructured":"Saunders J, Smith T. Malnutrition: causes and consequences. Clin Med (Lond) 2010;10:624\u2013627.","journal-title":"Clin Med (Lond)"},{"key":"9929_CR4","doi-asserted-by":"publisher","first-page":"e0701","DOI":"10.1097\/HC9.0000000000000701","volume":"9","author":"HE Johnston","year":"2025","unstructured":"Johnston HE, Mayr HL, Andelkovic M et al. Comparing the performance of 3 sarcopenia definitions for predicting adverse events prior to liver transplant. Hepatol Commun 2025;9:e0701.","journal-title":"Hepatol Commun"},{"key":"9929_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/lt.22167","volume":"16","author":"Elizabeth J Carey","year":"2010","unstructured":"Carey Elizabeth J, Steidley DE, Aqel BA et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplant 2010;16:1373\u20131378.","journal-title":"Liver Transplant"},{"key":"9929_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/ajt.17079","volume":"22","author":"Nghiem B Ha","year":"2022","unstructured":"Ha Nghiem B, Montano-Loza AJ, Carey EJ et al. Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis. Am JTransplant 2022;22:2195\u20132202.","journal-title":"Am JTransplant"},{"key":"9929_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","volume":"16","author":"AK Singal","year":"2012","unstructured":"Singal AK, Charlton MR. Nutrition in alcoholic liver disease. Clin Liver Dis 2012;16:805\u2013826.","journal-title":"Clin Liver Dis"},{"key":"9929_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","volume":"66","author":"RA Bhanji","year":"2017","unstructured":"Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology 2017;66:2055\u20132065. https:\/\/doi.org\/10.1002\/hep.29420.","journal-title":"Hepatology"},{"key":"9929_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ajg.2012.214","volume":"108","author":"ML Volk","year":"2013","unstructured":"Volk ML, Fisher N, Fontana RJ. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol 2013;108:302\u2013305. https:\/\/doi.org\/10.1038\/ajg.2012.214.","journal-title":"Am J Gastroenterol"},{"key":"9929_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77:1797\u20131835.","journal-title":"Hepatology"},{"key":"9929_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/LVT.0000000000000645","volume":"31","author":"Jessica PE Davis","year":"2025","unstructured":"Davis Jessica PE, Reticker A, Han H et al. Management of obesity in liver transplant candidates & recipients: rethinking the false dichotomy between pharmacotherapy and surgical intervention. Liver Transplant. 2025;31:10\u20131097.","journal-title":"Liver Transplant."},{"key":"9929_CR12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/LVT.0000000000000609","volume":"31","author":"NB Ha","year":"2025","unstructured":"Ha NB, Heimbach JK, Hameed B. Optimizing liver transplant candidacy in patients with cirrhosis and obesity. Liver Transplant 2025;31:1411\u20131422.","journal-title":"Liver Transplant"},{"key":"9929_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/HEP.0000000000000598","volume":"81","author":"KD Watt","year":"2025","unstructured":"Watt KD, Paul S, Khan MQ et al. Obesity management for the hepatologist\u2014What to do, how to do it and why? Hepatology 2025;81:1607\u20131620.","journal-title":"Hepatology"},{"key":"9929_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/TP.0000000000005361","volume":"109","author":"I Yakubu","year":"2025","unstructured":"Yakubu I, Spengler J, Taylor P et al. Impact of glucagon-like peptide-1 receptor agonists on metabolic health in liver transplant recipients. Transplantation 2025;109:501-e507.","journal-title":"Transplantation"},{"key":"9929_CR15","doi-asserted-by":"publisher","first-page":"017995","DOI":"10.1136\/bmjopen-2017-017995","volume":"9","author":"Hana Koutnikova","year":"2019","unstructured":"Koutnikova Hana, Genser B, Monteiro-Sepulveda M et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ open 2019;9:017995.","journal-title":"BMJ open"},{"key":"9929_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","volume":"391","author":"Rohit Loomba","year":"2024","unstructured":"Loomba Rohit, Hartman ML, Lawitz EJ et al. Tirzepatide for metabolic dysfunction\u2013associated steatohepatitis with liver fibrosis. New Engl J Med 2024;391:299\u2013310.","journal-title":"New Engl J Med"},{"key":"9929_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"European Association for the Study of the Liver, and European Association for the Study of Diabetes (EASD","year":"2024","unstructured":"European Association for the Study of the Liver, and European Association for the Study of Diabetes (EASD. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obesity Facts 2024;17:374\u2013444.","journal-title":"Obesity Facts"},{"key":"9929_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/LVT.0000000000000247","volume":"30","author":"Kenneth W Chow","year":"2024","unstructured":"Chow Kenneth W, Ibrahim B, Rahal K et al. Semaglutide is effective in achieving weight loss in liver transplant recipients. Liver Transplant 2024;30:223\u2013225.","journal-title":"Liver Transplant"},{"key":"9929_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/LVT.0000000000000233","volume":"30","author":"SH Richardson","year":"2024","unstructured":"Richardson SH, Wong G, Garner E, Izzy M, Srivastava G. Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients. Liver Transplant 2024;30:226\u2013228.","journal-title":"Liver Transplant"},{"key":"9929_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13668-025-00649-w","volume":"14","author":"Z Memel","year":"2025","unstructured":"Memel Z, Gold SL, Pearlman M, Muratore A, Martindale R. Impact of GLP- 1 receptor agonist therapy in patients high risk for sarcopenia. Current Nutr Rep 2025;14:63. https:\/\/doi.org\/10.1007\/s13668-025-00649-w.","journal-title":"Current Nutr Rep"},{"key":"9929_CR21","doi-asserted-by":"publisher","first-page":"101681","DOI":"10.1016\/j.diabet.2025.101681","volume":"51","author":"Andr\u00e9 J Scheen","year":"2025","unstructured":"Scheen Andr\u00e9 J. GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies. Diab Metabol. 2025;51:101681.","journal-title":"Diab Metabol."},{"key":"9929_CR22","doi-asserted-by":"publisher","first-page":"166770","DOI":"10.1016\/j.bbadis.2023.166770","volume":"1869","author":"S Iwai","year":"2023","unstructured":"Iwai S, Kaji K, Nishimura N et al. Glucagon-like peptide receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice. Biochim et Biophys Acta Mol Basis Dis 2023;1869:166770.","journal-title":"Biochim et Biophys Acta Mol Basis Dis"},{"key":"9929_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cgh.2020.10.034","volume":"19","author":"H Patton","year":"2020","unstructured":"Patton H, Heimbach J, McCullough A. AGA clinical practice update on bariatric surgery in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2020;19:436\u2013445. https:\/\/doi.org\/10.1016\/j.cgh.2020.10.034.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09929-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:13:36Z","timestamp":1787800416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09929-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09929-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}